Oppenheimer Expects Freshpet to Report Strong Q3 Results
Oppenheimer expects Freshpet to report strong third-quarter results despite a difficult backdrop.
Related stories
Array Technologies to Merge With Shoals in an All-Stock Deal
Array Technologies and Shoals will combine in an all-stock transaction.
M impact | EQUITY | Nov 04, 2026, 02:21 PM UTC
Immunome IM-1021 Shows 53% Response Rate in Early-Stage B-Cell Lymphoma Trial
M impact | EQUITY | Nov 04, 2026, 02:11 PM UTC
Plumas Bancorp Reports Third-Quarter Revenue of $29.3 Million
Third-quarter 2026 net income was $11.4 million, up from $5.1 million a year earlier, and diluted EPS rose to $1.61 from $0.73. Revenue increased 6.7% from $27.4 million.
M impact | EQUITY | Nov 04, 2026, 02:11 PM UTC
BIOREM Reports Q3 Revenue of CA$16.6M
BIOREM reported Q3 revenue of CA$16.6 million, versus a FactSet estimate of CA$13.3 million.
M impact | EQUITY | Nov 04, 2026, 02:10 PM UTC
Option Care Health Reports Q3 Earnings, Revenue Rise and Withdraws Guidance
Option Care Health reported higher Q3 adjusted earnings and revenue and withdrew guidance due to a pending merger.
M impact | EQUITY | Nov 04, 2026, 02:09 PM UTC
Burjeel Holdings and Burjeel Sukuk report third-quarter results
M impact | EQUITY | Nov 04, 2026, 02:09 PM UTC